Older, high-risk patients can safely defer percutaneous coronary intervention until after aortic valve replacement

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...

Direct comparison shows stroke protection devices during TAVR perform alike

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...
Healio

TAVR remains noninferior to surgery for low-risk patients at 5 years

Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...
Healio

TAVR continues to be comparable to surgery in patients at low surgical risk

Please provide your email address to receive an email when new articles are posted on . TAVR had similar clinical outcomes compared with surgery at 4 or 5 years in low-risk patients with severe aortic ...
Kaleido Scope

Still and Cardiothoracic Surgery faculty publish findings on outcomes for high-risk patients following TAVR explantations

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
KWQC

UnityPoint Health celebrates 600th TAVR operation for severe heart valve disease

ROCK ISLAND, Ill. (KWQC) - Hundreds of people have had a severe heart valve problems treated in the Quad Cities. UnityPoint Health is celebrating its 600th person to successfully receive a TAVR in the ...
MedPage Today

Mortality Signal Emerges 2 Years After Valve-in-Valve TAVR for Failed SAVR

For patients with failed bioprosthetic surgical valves, the choice of valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) carried upfront advantages, but was ultimately associated with ...
The Business Journals

Aurora St. Luke’s Medical Center celebrates its 5,000th TAVR procedure

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Aurora St. Luke’s Medical Center and its team of world ...

SoloPace Announces US Commercial Release of the SOLO PACE FUSION Temporary Pacing System Following FDA 510(k) Clearance

Solo Pace Incorporated, an emerging medical technology company, today announced the commercial release of the SoloPace ...
Medscape

Long-Term Data Confirm Advantage of Early Surgery in Asymptomatic Severe Aortic Stenosis

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic ...
News Medical

Embolic protection device does not reduce stroke rate in TAVR procedure

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...